LIVE BROADCAST: A New Targeted Therapy For Ovarian Cancer

In an upcoming broadcast, key opinion leaders will discuss clinical efficacy and safety data for a new targeted therapy.

To explore unmet needs for patients with ovarian cancer and obtain expert perspective, watch the live broadcast on 12/14, 6:00pm EST, 12/15, 7:00pm EST and 1/12/23, 8:00pm EST. To register for the event, visit https://studio.mjhassoc.com/reach/National-Broadcast.